A Clinical Study on Pre-operative Intervention With Products During Aesthetic Medicine
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age35-60
SponsorBotanee Group Co., Ltd.
About this trial
This clinical trial aims to evaluate whether a 14-day pre-operative application of the test product (containing MLYAAT-1002®, a proprietary anti-aging complex) can mitigate skin discomfort during Fotona 4D laser therapy (Frac3 and Piano modes) by comparing clinical evaluation, skin attributes measurement and subject self-assessment.
Eligibility criteria
Qualifiers
health females aged 35-60;
subjects with rough dark, loose fine lines;
no history of cosmetic allergies;
subjects are willing to use the test serum on split-face for 28 days;
Disqualifiers
anyone who is pregnant, nursing an infant, or planning a pregnancy during the study;
subjects with known allergies or sensitivities to the ingredients in any of the study products;
any symptoms of facial flushing, erythema, papules, desquamation, or edema as evaluated by a physician prior to initial screening or Fotona4D Pro treatment;
unhealed skin lesions;
Trial design
Treatments tested in this trial
- 14-day daily pre-operative application of the formulations containing MLYAAT-1002® before Fotona4D treatment
- 14-day daily pre-operative application of the formulations without MLYAAT-1002® before Fotona4D treatment
Treatment groups
33 Participants
are divided into 2 treatment groupsLocations
Sponsors and collaborators
Source ClinicalTrials.gov